It seems we can’t find what you’re looking for. Perhaps searching can help.
- 3411
[] Institution:Study Staff Contact – [3411] Trial:Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease (ZEST)